KUALA LUMPUR: The Malaysian Debt Ventures Bhd (MDV) is expecting RM973mil worth of deals this year.
The deals are expected to come from the information communication technology (ICT), biotechnology and green technology industries, said Zubir Ansori Yahaya, managing director and chief executive officer of MDV.
Out of the RM973mil target funding approval for this year, RM450mil has been approved by the Ministry of Finance (MOF), he said at a press conference today on the BioMalaysia 2012 Conference.
The conference is to be held here this November 5-7.
Meanwhile, Datuk Dr. Mohd Nazlee Kamal, chief executive officer of Malaysian Biotechnology Corporation Sdn Bhd, said Malaysia’s biotechnology industry was expected to contribute 4% to the country’s Gross Domestic Product (GDP) and 10% to the regional biotechnology market by the end of phase two.
The National Biotechnology Policy (NBP) is set to attract RM9bil worth of investments in the second phase from 2011 until 2015.
The biotechnology industry in Malaysia has marked impressive and encouraging achievements especially during the first phase of the NBP. Achievements set during the first phase are robust, whereby the industry has managed to attract RM5.4bil worth of investments, acquired a total of RM13.5bil in revenue, provided 54,776 jobs opportunities and contributed 2.2% towards GDP.